These findings underscore the importance of disaggregated analyses among Asian subpopulations to identify significant variations in the prevalence and odds of HER2-positive breast cancer, differences that may otherwise be overlooked when these groups are studied collectively. Here, ERBB2 is linked to breast cancer.